干扰素基因刺激剂
磷酸二酯酶
焦磷酸酶
酶
癌症免疫疗法
生物化学
小分子
干扰素
生物
化学
免疫疗法
细胞生物学
免疫系统
免疫学
胞浆
作者
Kenneth Ikenna Onyedibe,Modi Wang,Herman O. Sintim
出处
期刊:Molecules
[Multidisciplinary Digital Publishing Institute]
日期:2019-11-19
卷期号:24 (22): 4192-4192
被引量:130
标识
DOI:10.3390/molecules24224192
摘要
Ectonucleotide pyrophosphatase/phosphodiesterase I (ENPP1) was identified several decades ago as a type II transmembrane glycoprotein with nucleotide pyrophosphatase and phosphodiesterase enzymatic activities, critical for purinergic signaling. Recently, ENPP1 has emerged as a critical phosphodiesterase that degrades the stimulator of interferon genes (STING) ligand, cyclic GMP-AMP (cGAMP). cGAMP or analogs thereof have emerged as potent immunostimulatory agents, which have potential applications in immunotherapy. This emerging role of ENPP1 has placed this "old" enzyme at the frontier of immunotherapy. This review highlights the roles played by ENPP1, the mechanism of cGAMP hydrolysis by ENPP1, and small molecule inhibitors of ENPP1 with potential applications in diverse disease states, including cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI